Management of Locally Advanced Non Small Cell Lung Cancer from a Surgical Perspective Millie S. RoyJessica S. Donington Lung Cancer 19 June 2007 Pages: 1 - 14
Role of Anti-angiogenesis Agents in Treating NSCLC: Focus on Bevacizumab and VEGFR Tyrosine Kinase Inhibitors Elwyn CabebeHeather Wakelee Lung Cancer 08 June 2007 Pages: 15 - 27
“Who Should Receive Epidermal Growth Factor Receptor Inhibitors for Non-Small Cell Lung Cancer and When?” Christine L. HannJulie R. Brahmer Lung Cancer 14 June 2007 Pages: 28 - 37
Optimal Duration of Chemotherapy in Advanced Non-Small Cell Lung Cancer Maryam B. LustbergMartin J. Edelman Lung Cancer 07 June 2007 Pages: 38 - 46
The Role of Trastuzumab in Early Stage Breast Cancer: Current Data and Treatment Recommendations Amy LinHope S. Rugo Breast Carcinoma 28 July 2007 Pages: 47 - 60
New Insights into Breast Cancer Genetics and Impact on Patient Management Diana S. RosmanVirginia KaklamaniBoris Pasche Breast Carcinoma 07 June 2007 Pages: 61 - 73
Integrating Circulating Tumor Cell Assays into the Management of Breast Cancer Shaheenah DawoodMassimo Cristofanilli Breast Carcinoma 08 June 2007 Pages: 89 - 95
